Reactive Oxygen Species and Colorectal Cancer

Several agents used for treatment of colon and other cancers induce reactive oxygen species (ROS), and this plays an important role in their anticancer activities. In addition to the well-known proapoptotic effects of ROS inducers, these compounds also decrease expression of specificity protein (Sp)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current colorectal cancer reports 2013-12, Vol.9 (4), p.350-357
Hauptverfasser: Sreevalsan, Sandeep, Safe, Stephen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 357
container_issue 4
container_start_page 350
container_title Current colorectal cancer reports
container_volume 9
creator Sreevalsan, Sandeep
Safe, Stephen
description Several agents used for treatment of colon and other cancers induce reactive oxygen species (ROS), and this plays an important role in their anticancer activities. In addition to the well-known proapoptotic effects of ROS inducers, these compounds also decrease expression of specificity protein (Sp) transcription factors Sp1, Sp3, and Sp4 and several prooncogenic Sp-regulated genes important for cancer cell proliferation, survival, and metastasis. The mechanism of these responses involves ROS-dependent downregulation of miR-27a or miR-20a (and paralogs) and induction of two Sp repressors, ZBTB10 and ZBTB4, respectively. This pathway significantly contributes to the anticancer activity of ROS inducers and should be considered in the development of drug combinations for cancer chemotherapy.
doi_str_mv 10.1007/s11888-013-0190-5
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4288935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1826609027</sourcerecordid><originalsourceid>FETCH-LOGICAL-p309t-2db5d0c62b6f5876709d141c1686f7bb04f2b17dd16ac5e4efb503af37f26fd73</originalsourceid><addsrcrecordid>eNpVkVtLAzEQhYMotlZ_gC-yj76sTpLNZV8EKd6gUPDyHLLZpG7ZZtdkt9h_75a2og_DDJzhHGY-hC4x3GAAcRsxllKmgOlQOaTsCI0xYzylErLjwyxyGKGzGJcAGRZYnKIRYUxmkNExSl-tNl21tsn8e7OwPnlrralsTLQvk2lTN8GaTtfJVHtjwzk6cbqO9mLfJ-jj8eF9-pzO5k8v0_tZ2lLIu5SUBSvBcFJwx6TgAvISZ9hgLrkTRQGZIwUWZYm5Nsxm1hUMqHZUOMJdKegE3e18275Y2dJY3wVdqzZUKx02qtGV-q_46lMtmrXKiJQ5ZYPB9d4gNF-9jZ1aVdHYutbeNn1UWBLOIQeyzbr6m_UbcvjRsEB2C3GQ_MIGtWz64If7FQa1BaF2INQAQm1BKEZ_ABJzeOc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826609027</pqid></control><display><type>article</type><title>Reactive Oxygen Species and Colorectal Cancer</title><source>SpringerNature Journals</source><creator>Sreevalsan, Sandeep ; Safe, Stephen</creator><creatorcontrib>Sreevalsan, Sandeep ; Safe, Stephen</creatorcontrib><description>Several agents used for treatment of colon and other cancers induce reactive oxygen species (ROS), and this plays an important role in their anticancer activities. In addition to the well-known proapoptotic effects of ROS inducers, these compounds also decrease expression of specificity protein (Sp) transcription factors Sp1, Sp3, and Sp4 and several prooncogenic Sp-regulated genes important for cancer cell proliferation, survival, and metastasis. The mechanism of these responses involves ROS-dependent downregulation of miR-27a or miR-20a (and paralogs) and induction of two Sp repressors, ZBTB10 and ZBTB4, respectively. This pathway significantly contributes to the anticancer activity of ROS inducers and should be considered in the development of drug combinations for cancer chemotherapy.</description><identifier>ISSN: 1556-3790</identifier><identifier>EISSN: 1556-3804</identifier><identifier>DOI: 10.1007/s11888-013-0190-5</identifier><identifier>PMID: 25584043</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Colorectal Surgery ; Medicine ; Medicine &amp; Public Health ; Molecular Biology (S Anant ; Oncology ; Proctology ; Section Editor</subject><ispartof>Current colorectal cancer reports, 2013-12, Vol.9 (4), p.350-357</ispartof><rights>Springer Science+Business Media New York 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11888-013-0190-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11888-013-0190-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,315,781,785,886,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25584043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sreevalsan, Sandeep</creatorcontrib><creatorcontrib>Safe, Stephen</creatorcontrib><title>Reactive Oxygen Species and Colorectal Cancer</title><title>Current colorectal cancer reports</title><addtitle>Curr Colorectal Cancer Rep</addtitle><addtitle>Curr Colorectal Cancer Rep</addtitle><description>Several agents used for treatment of colon and other cancers induce reactive oxygen species (ROS), and this plays an important role in their anticancer activities. In addition to the well-known proapoptotic effects of ROS inducers, these compounds also decrease expression of specificity protein (Sp) transcription factors Sp1, Sp3, and Sp4 and several prooncogenic Sp-regulated genes important for cancer cell proliferation, survival, and metastasis. The mechanism of these responses involves ROS-dependent downregulation of miR-27a or miR-20a (and paralogs) and induction of two Sp repressors, ZBTB10 and ZBTB4, respectively. This pathway significantly contributes to the anticancer activity of ROS inducers and should be considered in the development of drug combinations for cancer chemotherapy.</description><subject>Colorectal Surgery</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Molecular Biology (S Anant</subject><subject>Oncology</subject><subject>Proctology</subject><subject>Section Editor</subject><issn>1556-3790</issn><issn>1556-3804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpVkVtLAzEQhYMotlZ_gC-yj76sTpLNZV8EKd6gUPDyHLLZpG7ZZtdkt9h_75a2og_DDJzhHGY-hC4x3GAAcRsxllKmgOlQOaTsCI0xYzylErLjwyxyGKGzGJcAGRZYnKIRYUxmkNExSl-tNl21tsn8e7OwPnlrralsTLQvk2lTN8GaTtfJVHtjwzk6cbqO9mLfJ-jj8eF9-pzO5k8v0_tZ2lLIu5SUBSvBcFJwx6TgAvISZ9hgLrkTRQGZIwUWZYm5Nsxm1hUMqHZUOMJdKegE3e18275Y2dJY3wVdqzZUKx02qtGV-q_46lMtmrXKiJQ5ZYPB9d4gNF-9jZ1aVdHYutbeNn1UWBLOIQeyzbr6m_UbcvjRsEB2C3GQ_MIGtWz64If7FQa1BaF2INQAQm1BKEZ_ABJzeOc</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Sreevalsan, Sandeep</creator><creator>Safe, Stephen</creator><general>Springer US</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131201</creationdate><title>Reactive Oxygen Species and Colorectal Cancer</title><author>Sreevalsan, Sandeep ; Safe, Stephen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p309t-2db5d0c62b6f5876709d141c1686f7bb04f2b17dd16ac5e4efb503af37f26fd73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Colorectal Surgery</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Molecular Biology (S Anant</topic><topic>Oncology</topic><topic>Proctology</topic><topic>Section Editor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sreevalsan, Sandeep</creatorcontrib><creatorcontrib>Safe, Stephen</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current colorectal cancer reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sreevalsan, Sandeep</au><au>Safe, Stephen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reactive Oxygen Species and Colorectal Cancer</atitle><jtitle>Current colorectal cancer reports</jtitle><stitle>Curr Colorectal Cancer Rep</stitle><addtitle>Curr Colorectal Cancer Rep</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>9</volume><issue>4</issue><spage>350</spage><epage>357</epage><pages>350-357</pages><issn>1556-3790</issn><eissn>1556-3804</eissn><abstract>Several agents used for treatment of colon and other cancers induce reactive oxygen species (ROS), and this plays an important role in their anticancer activities. In addition to the well-known proapoptotic effects of ROS inducers, these compounds also decrease expression of specificity protein (Sp) transcription factors Sp1, Sp3, and Sp4 and several prooncogenic Sp-regulated genes important for cancer cell proliferation, survival, and metastasis. The mechanism of these responses involves ROS-dependent downregulation of miR-27a or miR-20a (and paralogs) and induction of two Sp repressors, ZBTB10 and ZBTB4, respectively. This pathway significantly contributes to the anticancer activity of ROS inducers and should be considered in the development of drug combinations for cancer chemotherapy.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>25584043</pmid><doi>10.1007/s11888-013-0190-5</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1556-3790
ispartof Current colorectal cancer reports, 2013-12, Vol.9 (4), p.350-357
issn 1556-3790
1556-3804
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4288935
source SpringerNature Journals
subjects Colorectal Surgery
Medicine
Medicine & Public Health
Molecular Biology (S Anant
Oncology
Proctology
Section Editor
title Reactive Oxygen Species and Colorectal Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T01%3A55%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reactive%20Oxygen%20Species%20and%20Colorectal%20Cancer&rft.jtitle=Current%20colorectal%20cancer%20reports&rft.au=Sreevalsan,%20Sandeep&rft.date=2013-12-01&rft.volume=9&rft.issue=4&rft.spage=350&rft.epage=357&rft.pages=350-357&rft.issn=1556-3790&rft.eissn=1556-3804&rft_id=info:doi/10.1007/s11888-013-0190-5&rft_dat=%3Cproquest_pubme%3E1826609027%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826609027&rft_id=info:pmid/25584043&rfr_iscdi=true